KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Research & Development (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Research & Development readings, the most recent being $336.0 million for Q1 2026.

  • On a quarterly basis, Research & Development fell 1.75% to $336.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.4 billion, a 0.79% decrease, with the full-year FY2025 number at $1.4 billion, up 0.5% from a year prior.
  • Research & Development hit $336.0 million in Q1 2026 for Thermo Fisher Scientific, down from $356.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $391.0 million in Q4 2022 to a low of $319.0 million in Q3 2023.
  • Median Research & Development over the past 5 years was $346.0 million (2023), compared with a mean of $348.8 million.
  • Biggest five-year swings in Research & Development: decreased 16.37% in 2023 and later grew 14.37% in 2024.
  • Thermo Fisher Scientific's Research & Development stood at $391.0 million in 2022, then decreased by 16.37% to $327.0 million in 2023, then grew by 14.37% to $374.0 million in 2024, then fell by 4.81% to $356.0 million in 2025, then decreased by 5.62% to $336.0 million in 2026.
  • The last three reported values for Research & Development were $336.0 million (Q1 2026), $356.0 million (Q4 2025), and $346.0 million (Q3 2025) per Business Quant data.